Objectives: To study whether photon-counting computed tomography (PCCT) can improve CT number accuracy, precision and reduce patient size dependence compared to dual-energy CT (DECT) virtual monoenergetic imaging (VMI) and single-energy CT (SECT).

Methods: Clinical PCCT, DECT and SECT scanners were used to image a multi-energy quality assurance phantom and tissue-equivalent inserts with/without an outer nested annulus, representing two object sizes (18 and 33 cm). CT numbers were converted to linear attenuation coefficients (LAC) and regions-of-interest applied. Theoretical monoenergetic LAC were calculated from known elemental compositions as a ground truth. Percent difference in mean LAC between phantom sizes, between mean and theoretical LAC, and its coefficient of variation (COV) were calculated.

Results: Mean LAC percent differences between small and larger phantoms were highest in DECT (within -3% to 9%) and SECT (within 1% to 5%), particularly at higher calcium and iodine concentrations, while being relatively constant in PCCT over material concentrations and VMI energies (within ±2%). The COV in mean LAC was consistently lower (about 2 to 5 times) in PCCT relative to DECT and SECT for calcium in the large phantom. With consideration of the theoretical uncertainties of 2%, both PCCT and DECT showed comparable agreement to theoretical LAC.

Conclusions: PCCT VMI produces CT numbers with less dependence on patient size and increased precision in large object sizes than DECT VMI and SECT.

Advances In Knowledge: Clinical PCCT provides less variable CT numbers than DECT and SECT with less sensitivity to the imaged object size.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bjr/tqaf052DOI Listing

Publication Analysis

Top Keywords

patient size
12
dect sect
12
size dependence
8
dependence compared
8
clinical pcct
8
pcct dect
8
object sizes
8
pcct
7
dect
7
lac
6

Similar Publications

Objective: Evaluate Department of Defense (DoD) antimicrobial stewardship programs (ASPs) by assessing the relationship between key clinical outcome metrics (antibiotic use, incidence of resistant pathogens, and incidence of infections) and CDC Core Element (CE) adherence.

Design: Retrospective, cross-sectional study of DoD hospitals in 2018 and 2021.

Methods: National Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs) were used to measure antibiotic use and microbiology results to evaluate four types of pathogen incidence.

View Article and Find Full Text PDF

Objectives: Extracorporeal shock wave lithotripsy (ESWL) with endotherapy (ET) is the first-line treatment in patients with chronic pancreatitis (CP) and main pancreatic duct stone (PDS). Our study aimed to evaluate factors that predict the outcome of ESWL in CP patients with PDS.

Methods: We retrospectively analyzed data of 166 patients with CP and radiopaque PDS.

View Article and Find Full Text PDF

Breast cancer (BC) is one of the most common malignant tumors among women, accounting for 24.5% of all cancer cases and leading to 15.5% of cancer-related mortality.

View Article and Find Full Text PDF

Patients with severe hemophilia A (HA) often develop undesired immune responses to therapeutic factor VIII (FVIII) that hamper replacement therapy with FVIII-derived products. The transplacental delivery of two Fc-fused FVIII domains in pregnant HA mice was shown to induce partial FVIII-specific immune tolerance in the offspring. Here, we evaluated whether the transplacental delivery of Fc-fused FVIII (rFVIIIFc) induces complete immune tolerance towards FVIII.

View Article and Find Full Text PDF

Inorganic Nanomaterials Meet the Immune System: An Intricate Balance.

Adv Healthc Mater

March 2025

Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Cembrano 4, Genoa, 16148, Italy.

The immune system provides defense against foreign agents that are considered harmful for the organism. Inorganic nanomaterials can be recognized by the immune system as antigens, inducing an immune reaction dependent on the patient's immunological anamnesis and from several factors including size, shape, and the chemical nature of the nanoparticles. Furthermore, nanomaterials-driven immunomodulation might be exploited for therapeutic purposes, opening new horizons in oncology and beyond.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!